文献速递消化道肿瘤与早癌消化内镜

理解初级保健中症状性患者的结直肠癌风险:一项利用粪便免疫化学检测和血液结果的英格兰队列研究

Understanding colorectal cancer risk for symptomatic patients in primary care: A cohort study utilising faecal immunochemical tests and blood results in England.
PubMed 文献 · Aliment Pharmacol Ther · 2023-07-08

该队列研究基于英国诺丁汉初级保健的粪便免疫化学检测(FIT)路径,纳入33,694次FIT请求,随访1年诊断514例(1.5%)结直肠癌(CRC)。FIT≥10 μg Hb/g粪便者除40岁以下(风险1.45%)外CRC风险均>3%;非贫血且FIT<100 μg Hb/g者除70-85岁(5.26%)外风险<3%。作者认为单一FIT cut-off不足以优化CRC诊断,按年龄和贫血调整cut-off可在3%风险阈值下减少检查。

要点

  • FIT≥10 μg Hb/g粪便者CRC风险>3%,但40岁以下者仅1.45%。
  • 非贫血且FIT<100 μg Hb/g者CRC风险<3%,但70-85岁者达5.26%。
  • 作者认为单一FIT cut-off不足以优化CRC诊断。

核心结论

  • 单一FIT cut-off不太可能成为优化CRC诊断的万能方案,因为粪便血红蛋白低于100 μg Hb/g时风险随FIT、年龄和贫血变化。
  • 在3% CRC风险阈值下,按CRC路径调整FIT cut-off可减少所需检查数量。

研究设计与样本

  • 基于英国诺丁汉初级保健FIT检测的症状性CRC路径队列研究,时间范围为2017年11月至2021年,随访1年。

主要发现

  • 33,694次索引FIT请求后诊断514例CRC(1.5%)。
  • FIT≥10 μg Hb/g粪便者CRC风险>3%,但40岁以下患者CRC风险为1.45%(95%CI:0.03%-2.86%)。
  • 非贫血且FIT<100 μg Hb/g粪便者CRC风险<3%,但70至85岁者CRC风险为5.26%(95%CI:2.72%-7.73%)。
  • 在55岁以下患者中使用基于FIT、年龄和贫血计算的≥3% CRC阈值,可能使每10,000次FIT中的160-220次结肠镜检查被重新分配,代价是遗漏1-2例CRC。

关键数值与推荐

  • 英国目前推荐FIT≥10 μg Hb/g粪便作为结直肠癌紧急(疑似癌症)检查的门槛,基于预期的CRC风险阈值3%。
  • FIT≥10 μg Hb/g粪便者CRC风险>3%,但40岁以下患者风险为1.45%(95%CI:0.03%-2.86%)。
  • 非贫血且FIT<100 μg Hb/g粪便者CRC风险<3%,但70至85岁者风险为5.26%(95%CI:2.72%-7.73%)。
  • 在55岁以下患者中使用基于FIT、年龄和贫血的≥3% CRC阈值,可能使每10,000次FIT中的160-220次结肠镜检查被重新分配,代价是遗漏1-2例CRC。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: A faecal immunochemical tests (FIT) cut-off of ≥10 μg Hb/g faeces is now recommended in the UK as a gateway to urgent (suspected cancer) investigation for colorectal cancer (CRC), based on an expected CRC risk threshold of 3%. AIMS: To quantify the risk of CRC at FIT cut-offs by age, haemoglobin and platelet strata. METHODS: A cohort study of a symptomatic CRC pathway based on primary care FIT tests in Nottingham, UK (November 2017-2021) with 1-year follow-up. Heat maps showed the cumulative 1-year CRC risk using Kaplan-Meier estimates. RESULTS: In total, 514 (1.5%) CRCs were diagnosed following 33,694 index FIT requests. Individuals with a FIT ≥ 10 μg Hb/g faeces had a >3% risk of CRC, except patients under the age of 40 years (CRC risk 1.45% [95% CI: 0.03%-2.86%]). Non-anaemic patients with a FIT < 100 μg Hb/g faeces had a CRC risk of <3%, except those between the age of 70 and 85 years (5.26% 95% CI: 2.72%-7.73%). Using a ≥3% CRC threshold in patients <55 years calculated using FIT, age and anaemia might allow 160-220 colonoscopies per 10,000 FITs to be re-purposed, at a cost of missing 1-2 CRCs. CONCLUSIONS: FIT alone with a single cut-off is unlikely to be a panacea for optimising CRC diagnosis, as risk varies by FIT, age and anaemia when faecal haemoglobin levels are below 100 μg Hb/g. Tailored FIT cut-offs for investigation on a CRC pathway could reduce the number of investigations needed at a 3% CRC risk threshold.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Crooks CJ, Banerjea A, Jones J, et al. Understanding colorectal cancer risk for symptomatic patients in primary care: A cohort study utilising faecal immunochemical tests and blood results in England. Aliment Pharmacol Ther. 2023. PMID: 37421214. doi:10.1111/apt.17632

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。